|
87 |
Genematrix acquired a patent for the production method of Zika recombinant protein
|
2019.10.31 |
|
86 |
Genematrix, 5% equity investment in Calth... "Joint commercialization of POCT products"
|
2019.09.11 |
|
85 |
Genematrix merged with Genematrix Bio
|
2019.07.16 |
|
84 |
[Bio] "Even with a drop of blood, infections can be detected 99%."
|
2019.05.22 |
|
83 |
Genematrix, clinical presentation at the European Society of Clinical Microbiology
|
2019.04.15 |
|
82 |
Genematrix acquired European medical device certification for new molecular diagnostics for sexually transmitted infections
|
2019.04.11 |
|
81 |
Genematrix acquired a patent for proprietary technology for multiplex molecular diagnosis
|
2019.04.05 |
|
80 |
Genematrix acquired a new product license from KFDA for multiplex molecular diagnosis of pneumonia causative virus
|
2019.04.03 |
|
79 |
Genematrix invested 5.7 billion won in British company, Vaccitech... “Investment for joint :new drug development cooperation”
|
2018.12.20 |
|
78 |
Neoplex product lines successively acquired 'European CE certification'
|
2017.11.22 |
|
77 |
Genematrix signed a product supply contract with AB Analitica in Italy
|
2017.11.15 |
|
76 |
Genematrix acquired CE certification for multiplex detection kits for sexually transmitted infections
|
2017.11.13 |
|
75 |
Genematrix has successfully registered molecular diagnostic software as European medical device
|
2017.11.01 |
|
74 |
Genematrix is selected as a 2017 : Brain-Competency-Excellent Company
|
2017.10.27 |
|
73 |
Genematrix received favorable reviews for sexually transmitted infection diagnostic device
|
2017.10.20 |
ENG